Therapeutic interventions for systemic vasculitis

JAMA

Volumn 304, Issue 21, 2010, Pages 2413-2414

  Hoffman, Gary S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

BONE MARROW TOXICITY; DISEASE SEVERITY; DRUG CONTRAINDICATION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; KIDNEY FAILURE; MAINTENANCE THERAPY; MEDICAL DECISION MAKING; MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SYSTEMIC VASCULITIS; UNSPECIFIED SIDE EFFECT; WEGENER GRANULOMATOSIS;

EID: 78649743981     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2010.1676     Document Type: Editorial

References (13)

1. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J. 1958;2(5091):265-270.
2. Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyarteritis. Q J Med. 1985;56(220):467-483.
3. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis. Ann Intern Med. 1983;98(1):76-85.
4. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis. Ann Intern Med. 1992;116(6):488-498.
5. Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992;35(11):1322-1329.
6. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349(1):36-44. (Pubitemid 36765101)
7. de Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52(8):2461-2469. (Pubitemid 41117433)
8. Stone JH, Merkel PA, Spiera R, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221-232.
9. Pagnoux C, Mahr A, Hamidou MA, et al. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med. 2008;359(26):2790- 2803.
10. Hiemstra TF, Walsh M, Mahr A, et al; European Vasculitis Study Group (EUVAS). Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial [published online November 8, 2010]. JAMA. 2010;304(21):2381- 2388.
11. Wegener's Granulomatosis Etanercept Trial (WGET) Research Group. Etanercept plus standard therapy for Wegener's granulomatosis. N Engl J Med. 2005;352(4):351-361.
12. Finkielman JD, Merkel PA, Schroeder D, et al. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med. 2007;147(9):611-619. (Pubitemid 351664480)
13. Falk RJ, Hoffman GS. Controversies in small vessel vasculitis. Curr Opin Rheumatol. 2007;19(1):1-9.